Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PAND

Pandion Therapeutics (PAND) Stock Price, News & Analysis

Pandion Therapeutics logo

About Pandion Therapeutics Stock (NASDAQ:PAND)

Advanced Chart

Key Stats

Today's Range
$60.05
$60.05
50-Day Range
$59.90
$60.28
52-Week Range
$10.28
$62.90
Volume
N/A
Average Volume
355,921 shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PAND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pandion Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PAND Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Lawsuits News | Today's Latest Stories | Reuters
Pandion Therapeutics, Inc.
See More Headlines

PAND Stock Analysis - Frequently Asked Questions

Pandion Therapeutics, Inc. (NASDAQ:PAND) announced its quarterly earnings data on Monday, November, 16th. The company reported ($0.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.44) by $0.07. The firm earned $2.63 million during the quarter, compared to analyst estimates of $1 million.

Pandion Therapeutics (PAND) raised $94 million in an initial public offering (IPO) on Friday, July 17th 2020. The company issued 5,500,000 shares at $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley, SVB Leerink and BMO Capital Markets acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pandion Therapeutics investors own include Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Dynavax Technologies (DVAX), eBay (EBAY), Garmin (GRMN) and JD.com (JD).

Company Calendar

Last Earnings
11/16/2020
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PAND
CIK
N/A
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$970 thousand
Price / Sales
1,827.25
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
29,516,000
Free Float
N/A
Market Cap
$1.77 billion
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:PAND) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners